Amyloidosis
133
30
35
62
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
20 trials with published results (15%)
Research Maturity
62 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.8%
9 terminated out of 133 trials
87.3%
+0.7% vs benchmark
8%
11 trials in Phase 3/4
32%
20 of 62 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 62 completed trials
Clinical Trials (133)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
BE.Amycon Registry UZ Leuven
BE.Amycon Biobank & Data Registry UZ Leuven
A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Carpal Tunnel Release With Risk Factors for Amyloidosis
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
HIBA-Institutional Registry of Amyloidosis
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Dietary Reporting In The Amyloidoses
Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia
Prevalence and Significance of ATTR Aortic Valve Amyloidosis in Degenerative Aortic Stenosis